Expression of ErbB2 and ErbB3 in resected non- small cell lung cancer (NSCLC) patients (pts)

被引：1
|
作者：
Felip, E.
Salcedo, M.
Murtra-Garrell, N.
Navarro, A.
Teixido, C.
Hernandez-Losa, J.
Cedres, S.
Martinez, P.
Lopez, E.
Montero, M. A.
Freixinos, V.
Argiles, G.
Nunez, I.
Peg, V.
Pallisa, E.
Canela, M.
Tabernero, J.
Ramon y Cajal, S.
Tallada, N.
机构：
[1] Vall dHebron Univ Hosp, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Dept Stat, Barcelona, Spain
[4] Vall dHebron Univ Hosp, Dept Radiol, Barcelona, Spain
[5] Vall dHebron Univ Hosp, Dept Thorac Surg, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.7037
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7037
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] The Role of ERBB2/ERBB3 Signal Pathway in Generation of Cancer Stem Cells
    Hassan, Ghmkin
    Seno, Masaharu
    CANCER SCIENCE, 2021, 112 : 281 - 281
  • [32] Dual targeting of ErbB2/ErbB3 for treatment of SCL3A2-NRG1-mediated lung cancer
    Jo, Jeong Yeon
    Shin, Dong Hoon
    Han, Ji-Youn
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer
    Shin, Dong Hoon
    Jo, Jeong Yeon
    Han, Ji-Youn
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (09) : 2024 - 2033
  • [34] Nrdp1 and ErbB3 expression in non-small cell lung cancer cell lines.
    Plate, Janet M.
    Iyengar, Ravi M.
    Sutton, Parnetta
    Bonomi, Philip
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S381 - S381
  • [35] Prognostic value of ERBB2 amplification and protein expression in small cell lung cancer
    Cebollero Presmanes, Maria
    Sanchez-Mora, Nora
    Garcia-Gomez, Ramon
    Luisa Herranz Aladro, Maria
    Alvarez-Fernandez, Emilio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2008, 44 (03): : 122 - 126
  • [36] Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer
    Wei, Xue-Wu
    Gao, Xin
    Zhang, Xu-Chao
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Wu, Yi-Long
    Zhou, Qing
    THORACIC CANCER, 2020, 11 (06) : 1512 - 1521
  • [37] Evaluation of AZD8931, an Equipotent Inhibitor of erbB1, erbB2, and erbB3 Receptor Signaling, on Ligand Stimulated Breast Cancer Cell Lines with Differing Levels of erbB2 Expression
    Marshall, G.
    Klinowska, T. C. M.
    Mills, E. A.
    Ogilvie, D.
    Hickinson, D. M.
    Speake, G.
    CANCER RESEARCH, 2009, 69 (24) : 784S - 785S
  • [38] Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
    José Baselga
    Sandra M. Swain
    Nature Reviews Cancer, 2009, 9 : 463 - 475
  • [39] Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3
    Sak, Malgorzata Magdalena
    Szymanska, Monika
    Bertelsen, Vibeke
    Hasmann, Max
    Madshus, Inger Helene
    Stang, Espen
    CARCINOGENESIS, 2013, 34 (09) : 2031 - 2038
  • [40] Characterization of ERBB2 alterations in non-small cell lung cancer.
    Singh, Vijendra
    Feldman, Rebecca
    Sukari, Ammar
    Kim, Chul
    Mamdani, Hirva
    Spira, Alexander, I
    Bepler, Gerold
    Kim, Edward S.
    Raez, Luis E.
    Pai, Sachin Gopalkrishna
    Ikpeazu, Chukwuemeka
    Vanderwalde, Ari M.
    Xiu, Joanne
    Wozniak, Antoinette J.
    Borghaei, Hossein
    Liu, Stephen, V
    Nagasaka, Misako
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345